Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung

Robert J. Kaner, Ronald Crystal

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Background: Based on assessment of mRNA expression, the lung is a major site of expression of the vascular endothelial growth factor (VEGF) gene, largely from type II alveolar epithelial cells. With the knowledge that VEGF can function to induce vascular leak, we hypothesized that to protect the lung from pulmonary edema, the VEGF produced in the lung must be compartmentalized from the pulmonary endothelium, and thus must be compartmentalized to the surface of the respiratory epithelium. Material and Methods: To assess this hypothesis, we quantified the levels of VEGF in human respiratory epithelial lining fluid recovered by bronchoalveolar lavage from normal individuals. Results: Strikingly, human respiratory epithelial lining fluid contains 11 ± 5 ng/mL as quantified by ELISA, a 500-fold greater concentration than plasma (22 ± 10 pg/mL, p < 0.0005). Western analysis of BAL fluid proteins showed the major VEGF isoform in respiratory epithelial lining fluid is VEGF165. Conclusions: With the knowledge that proteins of molecular mass like VEGF (34 to 46 kDa) slowly diffuse across the alveolar epithelium, it is likely that this high level "reservoir" of VEGF protein on the respiratory epithelial surface plays a role in normal lung endothelial biology. However, this compartmentalized VEGF reservoir may also be a "Damocles sword" poised to induce lung endothelial permeability in conditions of acute lung injury when the integrity of the alveolar epithelial barrier is breached.

Original languageEnglish
Pages (from-to)240-246
Number of pages7
JournalMolecular Medicine
Volume7
Issue number4
Publication statusPublished - 1 Dec 2001
Externally publishedYes

Fingerprint

Vascular Endothelial Growth Factor A
Lung
Alveolar Epithelial Cells
Dimercaprol
Respiratory Mucosa
Proteins
Acute Lung Injury
Bronchoalveolar Lavage Fluid
Pulmonary Edema
Endothelium
Blood Vessels
Permeability
Protein Isoforms
Epithelium
Enzyme-Linked Immunosorbent Assay
Messenger RNA
Genes

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. / Kaner, Robert J.; Crystal, Ronald.

In: Molecular Medicine, Vol. 7, No. 4, 01.12.2001, p. 240-246.

Research output: Contribution to journalArticle

@article{c194395a58e341029841865e55e90819,
title = "Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung",
abstract = "Background: Based on assessment of mRNA expression, the lung is a major site of expression of the vascular endothelial growth factor (VEGF) gene, largely from type II alveolar epithelial cells. With the knowledge that VEGF can function to induce vascular leak, we hypothesized that to protect the lung from pulmonary edema, the VEGF produced in the lung must be compartmentalized from the pulmonary endothelium, and thus must be compartmentalized to the surface of the respiratory epithelium. Material and Methods: To assess this hypothesis, we quantified the levels of VEGF in human respiratory epithelial lining fluid recovered by bronchoalveolar lavage from normal individuals. Results: Strikingly, human respiratory epithelial lining fluid contains 11 ± 5 ng/mL as quantified by ELISA, a 500-fold greater concentration than plasma (22 ± 10 pg/mL, p < 0.0005). Western analysis of BAL fluid proteins showed the major VEGF isoform in respiratory epithelial lining fluid is VEGF165. Conclusions: With the knowledge that proteins of molecular mass like VEGF (34 to 46 kDa) slowly diffuse across the alveolar epithelium, it is likely that this high level {"}reservoir{"} of VEGF protein on the respiratory epithelial surface plays a role in normal lung endothelial biology. However, this compartmentalized VEGF reservoir may also be a {"}Damocles sword{"} poised to induce lung endothelial permeability in conditions of acute lung injury when the integrity of the alveolar epithelial barrier is breached.",
author = "Kaner, {Robert J.} and Ronald Crystal",
year = "2001",
month = "12",
day = "1",
language = "English",
volume = "7",
pages = "240--246",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",
number = "4",

}

TY - JOUR

T1 - Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung

AU - Kaner, Robert J.

AU - Crystal, Ronald

PY - 2001/12/1

Y1 - 2001/12/1

N2 - Background: Based on assessment of mRNA expression, the lung is a major site of expression of the vascular endothelial growth factor (VEGF) gene, largely from type II alveolar epithelial cells. With the knowledge that VEGF can function to induce vascular leak, we hypothesized that to protect the lung from pulmonary edema, the VEGF produced in the lung must be compartmentalized from the pulmonary endothelium, and thus must be compartmentalized to the surface of the respiratory epithelium. Material and Methods: To assess this hypothesis, we quantified the levels of VEGF in human respiratory epithelial lining fluid recovered by bronchoalveolar lavage from normal individuals. Results: Strikingly, human respiratory epithelial lining fluid contains 11 ± 5 ng/mL as quantified by ELISA, a 500-fold greater concentration than plasma (22 ± 10 pg/mL, p < 0.0005). Western analysis of BAL fluid proteins showed the major VEGF isoform in respiratory epithelial lining fluid is VEGF165. Conclusions: With the knowledge that proteins of molecular mass like VEGF (34 to 46 kDa) slowly diffuse across the alveolar epithelium, it is likely that this high level "reservoir" of VEGF protein on the respiratory epithelial surface plays a role in normal lung endothelial biology. However, this compartmentalized VEGF reservoir may also be a "Damocles sword" poised to induce lung endothelial permeability in conditions of acute lung injury when the integrity of the alveolar epithelial barrier is breached.

AB - Background: Based on assessment of mRNA expression, the lung is a major site of expression of the vascular endothelial growth factor (VEGF) gene, largely from type II alveolar epithelial cells. With the knowledge that VEGF can function to induce vascular leak, we hypothesized that to protect the lung from pulmonary edema, the VEGF produced in the lung must be compartmentalized from the pulmonary endothelium, and thus must be compartmentalized to the surface of the respiratory epithelium. Material and Methods: To assess this hypothesis, we quantified the levels of VEGF in human respiratory epithelial lining fluid recovered by bronchoalveolar lavage from normal individuals. Results: Strikingly, human respiratory epithelial lining fluid contains 11 ± 5 ng/mL as quantified by ELISA, a 500-fold greater concentration than plasma (22 ± 10 pg/mL, p < 0.0005). Western analysis of BAL fluid proteins showed the major VEGF isoform in respiratory epithelial lining fluid is VEGF165. Conclusions: With the knowledge that proteins of molecular mass like VEGF (34 to 46 kDa) slowly diffuse across the alveolar epithelium, it is likely that this high level "reservoir" of VEGF protein on the respiratory epithelial surface plays a role in normal lung endothelial biology. However, this compartmentalized VEGF reservoir may also be a "Damocles sword" poised to induce lung endothelial permeability in conditions of acute lung injury when the integrity of the alveolar epithelial barrier is breached.

UR - http://www.scopus.com/inward/record.url?scp=0035317643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035317643&partnerID=8YFLogxK

M3 - Article

C2 - 11471568

AN - SCOPUS:0035317643

VL - 7

SP - 240

EP - 246

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

IS - 4

ER -